Published in Mol Biol Cell on February 06, 2003
Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell (2009) 3.51
YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene (2012) 1.36
Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer (2003) 1.34
Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nat Rev Cancer (2013) 1.30
PTPN14 is required for the density-dependent control of YAP1. Genes Dev (2012) 1.23
PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene (2012) 1.17
Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia. Nat Commun (2012) 1.13
The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development. J Cell Biol (2007) 1.11
Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways. J Mol Histol (2004) 1.02
Sts-2 is a phosphatase that negatively regulates zeta-associated protein (ZAP)-70 and T cell receptor signaling pathways. J Biol Chem (2011) 1.00
Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans. Am J Hum Genet (2010) 0.99
The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity. PLoS One (2013) 0.95
Modulation of N-cadherin junctions and their role as epicenters of differentiation-specific actin regulation in the developing lens. Dev Biol (2010) 0.93
Regulation of adherens junction dynamics by phosphorylation switches. J Signal Transduct (2012) 0.92
The PI3K-PTEN tug-of-war, oxidative stress and retinal degeneration. Trends Mol Med (2009) 0.91
PTPN14 forms a complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic function. J Biol Chem (2014) 0.90
Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14. Oncogene (2012) 0.89
Genetic alterations of protein tyrosine phosphatases in human cancers. Oncogene (2014) 0.86
Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis. Sci Rep (2015) 0.85
Automated time-lapse microscopy and high-resolution tracking of cell migration. Cytotechnology (2006) 0.85
Protein tyrosine and serine-threonine phosphatases in the sea urchin, Strongylocentrotus purpuratus: identification and potential functions. Dev Biol (2006) 0.84
Gene expression profiling of rat spermatogonia and Sertoli cells reveals signaling pathways from stem cells to niche and testicular cancer cells to surrounding stroma. BMC Genomics (2011) 0.83
Distinct roles for N-Cadherin linked c-Src and fyn kinases in lens development. Dev Dyn (2013) 0.83
Diverse levels of sequence selectivity and catalytic efficiency of protein-tyrosine phosphatases. Biochemistry (2014) 0.80
Three-step method for proliferation and differentiation of human embryonic stem cell (hESC)-derived male germ cells. PLoS One (2014) 0.78
The Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and Beyond. Genes (Basel) (2016) 0.76
YAP-Mediated Mechanotransduction in Skeletal Muscle. Front Physiol (2016) 0.76
A central role for cadherin signaling in cancer. Exp Cell Res (2017) 0.75
High expression of PTPN21 in B-cell non-Hodgkin's gastric lymphoma, a positive mediator of STAT5 activity. Blood Cancer J (2016) 0.75
Customized Array Comparative Genomic Hybridization Analysis of 25 Phosphatase-encoding Genes in Colorectal Cancer Tissues. Cancer Genomics Proteomics (2016) 0.75
The PTPN14 tumour suppressor is a degradation target of Human Papillomavirus E7. J Virol (2017) 0.75
Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium. Carcinogenesis (2016) 0.75
Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol (1993) 5.86
Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci U S A (1997) 5.63
Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol (2002) 5.02
Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. J Biol Chem (1999) 3.53
The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci (1998) 3.24
Factors influencing endothelial cell proliferation in vitro. J Cell Physiol (1978) 2.99
Signal transduction of beta-catenin. Curr Opin Cell Biol (1995) 2.96
Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun (1994) 2.87
The p120 catenin family: complex roles in adhesion, signaling and cancer. J Cell Sci (2000) 2.65
Cadherins and tissue formation: integrating adhesion and signaling. Bioessays (1999) 2.05
Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res (2002) 2.05
Cadherins and their connections: adhesion junctions have broader functions. Curr Opin Cell Biol (1999) 1.93
Cytoskeleton-membrane interactions. Curr Opin Cell Biol (1996) 1.83
Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J Biol Chem (1999) 1.75
Altered cell adhesion activity by pervanadate due to the dissociation of alpha-catenin from the E-cadherin.catenin complex. J Biol Chem (1998) 1.74
The tight junction: morphology to molecules. Annu Rev Cell Dev Biol (1998) 1.62
Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor. Lab Invest (1997) 1.39
Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability. J Biol Chem (2001) 1.30
Translocation of protein tyrosine phosphatase Pez/PTPD2/PTP36 to the nucleus is associated with induction of cell proliferation. J Cell Sci (2000) 1.04
Pez: a novel human cDNA encoding protein tyrosine phosphatase- and ezrin-like domains. Biochem Biophys Res Commun (1995) 0.97
Involvement of phosphatidylinositol 3-kinase and mitogen-activated protein kinases in glycine-extended gastrin-induced dissociation and migration of gastric epithelial cells. J Biol Chem (2001) 0.89
Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function. Cell Biol Int (2001) 0.86
Cyclic changes in the organization of cell adhesions and the associated cytoskeleton, induced by stimulation of tyrosine phosphorylation in bovine aortic endothelial cells. J Cell Sci (1997) 0.86
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J (2003) 2.93
An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell (2011) 2.49
Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J Exp Med (2004) 2.10
Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling. J Biol Chem (2002) 1.97
Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J Cell Biol (2006) 1.52
Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood (2005) 1.47
Assessing IRES activity in the HIF-1alpha and other cellular 5' UTRs. RNA (2006) 1.45
The microRNA-200 family regulates epithelial to mesenchymal transition. ScientificWorldJournal (2008) 1.44
Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol Endocrinol (2003) 1.35
Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. Neoplasia (2013) 1.25
Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state. J Cell Sci (2013) 1.24
Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood (2008) 1.15
The nucleotide-binding site of human sphingosine kinase 1. J Biol Chem (2002) 1.14
A multi-protein complex containing cold shock domain (Y-box) and polypyrimidine tract binding proteins forms on the vascular endothelial growth factor mRNA. Potential role in mRNA stabilization. Eur J Biochem (2004) 1.13
Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway. Endocrinology (2009) 1.13
The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development. J Cell Biol (2007) 1.11
The calmodulin-binding site of sphingosine kinase and its role in agonist-dependent translocation of sphingosine kinase 1 to the plasma membrane. J Biol Chem (2006) 1.08
High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation (2004) 1.04
A vascular cell-restricted RhoGAP, p73RhoGAP, is a key regulator of angiogenesis. Proc Natl Acad Sci U S A (2004) 1.04
Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects. Int J Cancer (2006) 1.02
Role of protein kinase Czeta in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1. Blood (2004) 1.01
Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development. J Natl Cancer Inst (2006) 1.00
Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells. Circ Res (2005) 0.99
Deactivation of sphingosine kinase 1 by protein phosphatase 2A. J Biol Chem (2008) 0.95
Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3beta and repression of the human VEGF promoter. FEBS Lett (2005) 0.94
The human IL-3 locus is regulated cooperatively by two NFAT-dependent enhancers that have distinct tissue-specific activities. J Immunol (2002) 0.94
miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer. Liver Int (2014) 0.94
Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity. J Biol Chem (2008) 0.93
Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol (2009) 0.93
The secretome in cancer progression. Biochim Biophys Acta (2013) 0.93
An assay for sphingosine kinase activity using biotinylated sphingosine and streptavidin-coated membranes. Anal Biochem (2004) 0.91
JAM-C induces endothelial cell permeability through its association and regulation of {beta}3 integrins. Arterioscler Thromb Vasc Biol (2009) 0.91
PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase. Circ Res (2004) 0.90
Stress-induced premature senescence mediated by a novel gene, SENEX, results in an anti-inflammatory phenotype in endothelial cells. Blood (2010) 0.89
Activation of endothelial extracellular signal-regulated kinase is essential for neutrophil transmigration: potential involvement of a soluble neutrophil factor in endothelial activation. J Immunol (2003) 0.87
Sphingosine kinase regulates the rate of endothelial progenitor cell differentiation. Blood (2008) 0.87
A proinflammatory role for proteolytically cleaved annexin A1 in neutrophil transendothelial migration. J Immunol (2010) 0.86
A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts. Nucleic Acids Res (2002) 0.85
Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells. Cell Mol Biol Lett (2009) 0.84
Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27. Blood (2013) 0.84
The effects of markedly raised intracellular sphingosine kinase-1 activity in endothelial cells. Cell Mol Biol Lett (2009) 0.84
Endothelial cell COX-2 expression and activity in hypoxia. Biochim Biophys Acta (2006) 0.84
Identification of an enhancer that increases miR-200b~200a~429 gene expression in breast cancer cells. PLoS One (2013) 0.82
Age-associated stresses induce an anti-inflammatory senescent phenotype in endothelial cells. Aging (Albany NY) (2013) 0.82
PTP-Pez: a novel regulator of TGFbeta signaling. Cell Cycle (2008) 0.82
The CCT/TRiC chaperonin is required for maturation of sphingosine kinase 1. Int J Biochem Cell Biol (2008) 0.81
ARHGAP18: an endogenous inhibitor of angiogenesis, limiting tip formation and stabilizing junctions. Small GTPases (2014) 0.81
Rate of endothelial expansion is controlled by cell:cell adhesion. Int J Biochem Cell Biol (2002) 0.80
Caveolae control the anti-inflammatory phenotype of senescent endothelial cells. Aging Cell (2014) 0.79
Stromal miR-320 keeps an oncogenic secretome in check. Nat Cell Biol (2012) 0.79
Sphingosine kinase-1 associates with integrin {alpha}V{beta}3 to mediate endothelial cell survival. Am J Pathol (2009) 0.78
Beyond liver fibrosis: hepatic stellate cell senescence links obesity to liver cancer by way of the microbiome. Hepatology (2014) 0.77
Molecular cloning and domain structure of chicken pyruvate carboxylase. Biochem Biophys Res Commun (2002) 0.76
Active subnetwork recovery with a mechanism-dependent scoring function; with application to angiogenesis and organogenesis studies. BMC Bioinformatics (2013) 0.75
Insights into defibrotide as therapy for veno-occlusive disease. Hepatology (2009) 0.75
New therapeutic targets in vascular biology. Thromb Haemost (2003) 0.75